全球臉部美容市場 - 2023-2030
市場調查報告書
商品編碼
1347965

全球臉部美容市場 - 2023-2030

Global Facial Aesthetics Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年,全球臉部美容市場規模達到65億美元,預計到2030年將達到193億美元,2023-2030年預測期間年複合成長率為9.1%。

臉部美容是一種非手術和微創手術,可以暫時減少皺紋或恢復皺紋。常見的治療區域包括前額、臉頰和嘴唇。產品推出的增加和臉部手術需求的增加是市場的促進因素。

預計北美地區將在市場佔有率中佔據重要地位。手術數量和產品發布數量的增加使該地區佔據了主導地位。

臉部美容市場研究分析提供了包含定量和定性數據的市場深入展望。它根據市場細分對全球市場進行了展望和預測。

動力學

產品發布數量的增加正在推動市場成長

產品發布數量的增加正在推動市場成長。例如,2023 年 1 月 17 日,艾伯維 (AbbVie) 旗下公司 Allergan Aesthetics 推出了期待已久的 SkinMedica Even & Correct 系列。這些先進的美白護理產品、黑斑霜和美白治療墊經過臨床驗證,其配方可提供有針對性的效果,可單獨或共同發揮作用,均勻膚色,減少臉部色素沉著和黑斑的出現。

此外,2023 年 1 月 10 日,總部位於孟買的 ENTOD Pharmaceuticals 推出了新的眼科美容系列,專注於改善眼睛舒適度並增強眼睛的美觀。這些產品已以 Eyecirque、Lashfactor 和 Vasuki 品牌推出。 Eyecirque 系列包括世界上第一個基於奈米技術的凝膠精華液、眼下皮膚提亮和抗衰老片劑、潤滑滴眼液和基本眼部補充劑。因此,產品推出的增加將加速市場成長。

關鍵參與者對臉部美容手術和策略的需求不斷增加將推動市場成長

對臉部美容手術的需求增加增加了產品的推出,從而推動了市場的成長。例如,2023 年 1 月 9 日,國際美容整形外科學會 (ISAPS) 發布了其年度全球美容/整容手術調查結果,顯示 2021 年整形外科醫生實施的手術總體增加了 19.3%,其中更多全球範圍內實施了超過1,280 萬例外科手術和1,750 萬例非外科手術。

這些公司製定的戰略,如合作、夥伴關係等,預計將推動市場成長。例如,2021 年 1 月 15 日,全球醫學美容領域的領導者 Merz Aesthetics 與美容器械公司 Candela Corporation 啟動了商業合作,為全球消費者提供廣泛的醫學美容產品組合。

此外,2022 年 5 月 24 日,全球領先的全面一體化護膚公司 Crown Laboratories 收購了其全球專注於美容的資產。此次收購擴大了 Crown 的美容產品組合,並增強了 Crown 作為基於科學的美容護膚解決方案全球領導者的整體價值主張。因此,上述因素預計將推動市場成長。

產品和治療的高成本預計將阻礙市場成長

這些臉部美容手術價格昂貴,高成本成為市場成長的障礙。例如,根據美國整形外科醫生協會的最新統計數據,整容的平均費用為 8,005 美元。外科醫生收取的費用是決定整體治療費用的關鍵因素之一。除了外科醫生之外,麻醉師的費用也增加了治療費用。根據程序的複雜性和要求,成本會增加。因此,它成為市場成長的阻礙因素。

目錄

第 1 章:方法和範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義和概述

第 3 章:執行摘要

  • 按產品分類
  • 按應用程式片段
  • 最終用戶的片段
  • 按地區分類

第 4 章:動力學

  • 影響因素
    • 動力
      • 產品發布數量增加
      • 關鍵參與者對臉部美容程序和策略的需求不斷增加
    • 限制
      • 產品和治療成本高
    • 機會
    • 影響分析

第 5 章:行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情后的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商戰略舉措
  • 結論

第 7 章:副產品

  • 真皮填充劑
  • 肉毒桿菌毒素
  • 化學換膚術
  • 微晶煥膚術

第 8 章:按應用

  • 臉部線條矯正治療
  • 疤痕治療
  • 唇部護理
  • 恢復體積/豐滿度
  • 其他

第 9 章:最終用戶

  • 醫院
  • 專科診所
  • 皮膚科診所
  • 其他

第 10 章:按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第 11 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章:公司簡介

第 13 章:高德美控股 SA *

    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • 梅爾茲製藥有限責任公司
  • 蘇內瓦醫療
  • 科曼博士實驗室有限公司
  • 辛克萊製藥公司
  • 四惡烷
  • 華熙生物
  • 強生醫療科技
  • 索爾塔醫療
  • 指娛天地有限公司

第 14 章:附錄

簡介目錄
Product Code: MD2244

Overview

Global Facial Aesthetics Market reached US$ 6.5 billion in 2022 and is expected to reach US$ 19.3 billion by 2030, growing with a CAGR of 9.1% during the forecast period 2023-2030.

Facial aesthetics are a non-surgical and minimally invasive procedure that can temporarily diminish wrinkles or restore volume. Common treatment areas include the forehead, cheeks, and lips. An increase in product launches and an increase in the demand for facial surgeries are driving factors for the market.

The North America region is expected to hold a significant position in the market share. The increase in the number of procedures and product launches is holding the region in the dominant share.

Facial Aesthetics Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation.

Dynamics

Increase in the Number of Product Launches is Driving the Market Growth

The increase in the number of product launches is driving the market growth. For instance, on January 17, 2023, Allergan Aesthetics, an AbbVie company, launched the long-awaited SkinMedica Even & Correct Collection. Clinically proven and formulated to deliver targeted results, these advanced brightening treatments, dark spot creams, and brightening treatment pads work separately and together to even skin tone and reduce the appearance of hyperpigmentation and dark spots on the face.

Additionally, on January 10, 2023, Mumbai-based ENTOD Pharmaceuticals launched its new ocular aesthetic range focused on improving eye comfort and enhancing the aesthetics of the eyes. The products have been launched under the Eyecirque, Lashfactor, and Vasuki brands. The Eyecirque range comprises the world's first nanotechnology-based gel serum, under-eye skin brightening and anti-aging tablets, lubricating eye drops, and essential eye supplements. Thus, an increase in product launches will accelerate the market growth.

Increasing Demands for Facial Aesthetic Procedures and Strategies by the Key Players will Drive Market Growth

The increase in the demand for facial aesthetic procedures increases the product launches, which are driving the market growth. For instance, on January 9, 2023, the International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual global survey on Aesthetic/Cosmetic Procedures, showing a 19.3% overall increase in procedures performed by plastic surgeons in 2021, with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed worldwide.

The strategies developed by the companies, such as collaborations, partnerships, and others, are expected to drive market growth. For instance, on January 15, 2021, Merz Aesthetics, the world leader in medical aesthetics, and Candela Corporation, an aesthetic device company, launched a commercial collaboration to provide a broad medical aesthetics portfolio to consumers across the globe.

Additionally, May 24, 2022, Crown Laboratories, a leading, fully integrated global skincare company, has acquired its global aesthetics-focused assets. The acquisition expands Crown's aesthetics product portfolio and enhances Crown's overall value proposition as a global leader in science-based aesthetic skincare solutions. Thus, the above factors are expected to drive the market growth.

High Cost of the Products and Treatments are Expected to Hamper the Market Growth

These facial aesthetic procedures are expensive, and the high cost becomes a barrier to market growth. For instance, according to the American Society of Plastic Surgeons, The average cost of a facelift is $8,005, according to the most recent statistics from the American Society of Plastic Surgeons. The fee charged by the surgeon is one of the key factors determining the overall treatment cost. Besides the surgeon, the anesthetist's fee also adds to the treatment cost. Depending on the complexity and requirements of the procedure, the cost increases. Thus, it acts as a restraining factor for the market growth.

Segment Analysis

The global facial aesthetics market is segmented based on product, application, end-user, and region.

Derma Fillers Segment is Expected to Hold the Largest Market Share in the Global Facial Aesthetics Market

The derma fillers segment holds a significant share in the global facial aesthetics market. The increase in the number of FDA approvals of the products drives the segment growth. For instance, on May 19, 2023, Sculptra Aesthetic, the first poly-L-lactic acid (PLLA) Derma filler used to restore natural-looking facial volume, was recently granted FDA approval to treat fine lines and wrinkles throughout the cheek area.

Additionally, on May 15, 2023, Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of SKINVIVE by JUVEDERM to improve skin smoothness of the cheeks in adults over the age of 21. SKINVIVE by JUVEDERM is the first and only hyaluronic acid (HA) intraDerma microdroplet injection for skin smoothness available in the U.S., with results lasting through six months with optimal treatment. Thus, the increased product approvals are holding the segment in the dominant position in the market share.

Geographical Penetration

North America is Expected to Hold a Significant Position in the Global Facial Aesthetics Market Share

North America is a dominant force in the global facial aesthetics market share. With the increase in the demand for facial surgeries, there is an increase in the number of launches of treatment procedures. For instance, according to ClevelandClinic Organization it is estimated that every year, providers perform more than 15 million cosmetic surgery procedures in the United States. More than 13 million of those are minimally invasive procedures.

Additionally increase in the demand for surgeries increases the launch of the products. For instance, on August 18, 2023, Movel Medical Aesthetics, a state-of-the-art and unique mobile Med Spa for facial aesthetics introduced the revolutionary Fotona 4D, Eyelase, and LipLase procedures to its service offering for patients. Thus, the above factors are holding the region in the dominant position of the market share.

COVID-19 Impact Analysis

COVID-19 has impacted the growth of the facial aesthetics market. There are a number of individuals who frequently approach clinics and facial aesthetics centers for surgeries. Due to the pandemic, the clinics were shut down. Having most facial aesthetics surgery cases as elective operations, plastic and aesthetic surgery became one of the branches most affected by the pandemic process.

A drastic decline was experienced in the number of plastic surgeries. The stringent rules and regulations have impacted the market growth. The implementation of lockdown has restricted people from visiting the clinics and continuing the treatment process. The restrictions helped in preventing the spread of the virus. However, there was an increase in demand that occurred in the period after the restrictions.

By Product

  • Derma Fillers
  • Botulinum Toxin
  • Chemical Peel
  • Microdermabrasion

By Application

  • Facial Line Correction Treatment
  • Scar Treatment
  • Lip Treatments
  • Restoration of Volume/ Fullness
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Dermatology Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The global facial aesthetics market is fragmented, with the presence of many local and international players. Galderma Holding SA, Merz Pharmaceuticals, LLC, Suneva Medical, Dr. Korman Laboratories Ltd., Sinclair Pharma, Teoxane, Bloomage Biotech, Johnson & Johnson MedTech, Solta Medical, and Cynosure LLC are the leading companies with a significant market share.

Why Purchase the Report?

  • To visualize the global facial aesthetics market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of facial aesthetics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global facial aesthetics market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the number of product launches
      • 4.1.1.2. Increasing demands for facial aesthetic procedures and strategies by the key players
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of the products and treatments
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Derma Fillers *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Botulinum Toxin
  • 7.4. Chemical Peel
  • 7.5. Microdermabrasion

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Facial Line Correction Treatment *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Scar Treatment
  • 8.4. Lip Treatments
  • 8.5. Restoration of Volume/ Fullness
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Dermatology Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

13. Galderma Holding SA *

    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Merz Pharmaceuticals, LLC
  • 13.3. Suneva Medical
  • 13.4. Dr. Korman Laboratories Ltd.
  • 13.5. Sinclair Pharma
  • 13.6. Teoxane
  • 13.7. Bloomage Biotech
  • 13.8. Johnson & Johnson MedTech
  • 13.9. Solta Medical
  • 13.10. Cynosure LLC

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us